Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

Clinical trial NCT05216510 · TERMINATED

Trial details

NCT number: NCT05216510
Sponsor: Tonix Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

Start date: 2022-01-07
Primary completion: 2022-09-17
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.